menu
    • menu

    Company profile for Cardiff Oncology

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clini...
    At Cardiff Oncology, our mission is to turn the tide on cancer by developing onvansertib, a first-in-class, third generation Polo-like Kinase 1 (PLK1) inhibitor, to treat cancers with the greatest medical need for new therapeutic options to overcome resistance, improve response and increase overall survival. Onvansertib, our investigational drug, is demonstrating safety and clinical benefit in all three of our ongoing clinical trials.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cardiff OncologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11055 Flintkote Avenue San Diego, CA 92121
    Telephone
    Telephone
    +1 858-952-7570
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://cardiffoncology.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiff Oncology Grants Inducement Under Nasdaq Rule 5635(c)(4)
    Cardiff Oncology Grants Inducement Under Nasdaq Rule 5635(c)(4)

    28 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/28/3283151/0/en/cardiff-oncology-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4.html

    GLOBENEWSWIRE
    28 Apr 2026
    Share Share
    Cardiff Oncology Updates Onvansertib mCRC Phase 2 Data at ASCO
    Cardiff Oncology Updates Onvansertib mCRC Phase 2 Data at ASCO

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7198562

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Cardiff Oncology Unveils Onvansertib Data With Her2-Targeted ADC
    Cardiff Oncology Unveils Onvansertib Data With Her2-Targeted ADC

    19 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7187992

    FIRSTWORD PHARMA
    19 Apr 2026
    Share Share
    Cardiff Oncology Strengthens Executive Team For Growth Phase
    Cardiff Oncology Strengthens Executive Team For Growth Phase

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3271396/0/en/Cardiff-Oncology-Announces-Key-Leadership-Appointments-to-Strengthen-Executive-Team-for-Next-Phase-of-Growth.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Cardiff Oncology Hosts KOL Talk On RAS+ Metastatic CRC Cancer
    Cardiff Oncology Hosts KOL Talk On RAS+ Metastatic CRC Cancer

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259664/0/en/Cardiff-Oncology-to-Host-Key-Opinion-Leader-Discussion-Focusing-on-First-Line-RAS-mutated-Metastatic-Colorectal-Cancer.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share
    Cardiff Oncology to Host Key Opinion Leader Discussion
    Cardiff Oncology to Host Key Opinion Leader Discussion

    20 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/20/3259664/0/en/Cardiff-Oncology-to-Host-Key-Opinion-Leader-Discussion-Focusing-on-First-Line-RAS-mutated-Metastatic-Colorectal-Cancer.html

    GLOBENEWSWIRE
    20 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search